GE HealthCare Technologies (GEHC) Expected to Announce Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) is expected to release its Q2 2025 earnings data before the market opens on Wednesday, July 30th. Analysts expect GE HealthCare Technologies to post earnings of $0.91 per share and revenue of $4.96 billion for the quarter. GE HealthCare Technologies has set its FY 2025 guidance at 3.900-4.100 EPS.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.10. GE HealthCare Technologies had a return on equity of 24.95% and a net margin of 11.02%. The firm had revenue of $4.78 billion during the quarter, compared to analyst estimates of $4.66 billion. During the same quarter last year, the firm earned $0.90 EPS. GE HealthCare Technologies's quarterly revenue was up 2.7% on a year-over-year basis. On average, analysts expect GE HealthCare Technologies to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

GE HealthCare Technologies Stock Up 3.1%

GEHC opened at $76.49 on Wednesday. GE HealthCare Technologies has a one year low of $57.65 and a one year high of $94.80. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.76 and a current ratio of 0.98. The company has a market capitalization of $35.02 billion, a PE ratio of 16.10, a P/E/G ratio of 2.50 and a beta of 1.14. The stock's fifty day moving average is $72.98 and its 200-day moving average is $77.22.

GE HealthCare Technologies announced that its board has authorized a share buyback plan on Wednesday, April 30th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to repurchase up to 3.1% of its shares through open market purchases. Shares buyback plans are often a sign that the company's board of directors believes its stock is undervalued.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 25th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.18%. GE HealthCare Technologies's dividend payout ratio (DPR) is 2.95%.

Analysts Set New Price Targets

GEHC has been the topic of several recent analyst reports. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. UBS Group raised GE HealthCare Technologies from a "sell" rating to a "neutral" rating and lowered their target price for the stock from $74.00 to $73.00 in a research report on Monday, May 5th. Piper Sandler dropped their price target on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Morgan Stanley lowered their price target on shares of GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Finally, Citigroup upped their target price on shares of GE HealthCare Technologies from $86.00 to $89.00 and gave the stock a "buy" rating in a research report on Wednesday, July 9th. Three equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $88.55.

Institutional Trading of GE HealthCare Technologies

A hedge fund recently bought a new stake in GE HealthCare Technologies stock. Acadian Asset Management LLC acquired a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 3,216 shares of the company's stock, valued at approximately $259,000. 82.06% of the stock is owned by institutional investors and hedge funds.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.